|
Arena Pharmaceuticals posts narrower 4Q loss
Forbes The drugmaker said it studied more than 7000 patients who were treated for up to two years, and subjects showed significant weight loss in both trials. … Arena Pharmaceuticals Q4 Loss Narrows – UpdateRTT News Arena will launch lorcaserin with partner or aloneReuters Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial …PR Newswire (press release) all 28 news articles » |
Original post click here
















Entries (RSS)